Anticancer activity of esculetin via-modulation of Bcl-2 and NF-κB expression in benzo[a]pyrene induced lung carcinogenesis in mice

Biomedicine and Preventive Nutrition

Volumn 3, Issue 2, 2013, Pages 107-112

  Anand, Jay R ^a   Rijhwani, Harish ^a   Malapati, Kanakadurga ^a   Kumar, Parveen ^a   Saikia, Kandarpa ^b   Lakhar, Mangala ^a,c  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b Department of Biotechnology and Bioengineering   (India)

^c GAUHATI MEDICAL COLLEGE   (India)

Author keywords

Bcl 2; Benzo a pyrene; Chemoprevention; Esculetin; NF B

Indexed keywords

BENZO[A]PYRENE; ESCULETIN; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; LIPID PEROXIDATION; LUNG CARCINOGENESIS; MALE; MODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TREATMENT RESPONSE;

MUS;

EID: 84879135693     PISSN: 22105239     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bionut.2012.11.004     Document Type: Article

References (52)

1. World Health Organization. Fact Sheet No 297: Cancer. February 2012. Available at. Accessed on September 5th 2012. http://www.who.int/mediacentre/factsheets/fs297/en/index.html.
2. GLOBOCAN 2002, 2008 database (India). Available at. Accessed on September 5th 2012. http://globocan.iarc.fr/factsheet.asp.
3. Hecht S.S. Smoking and lung cancer - a new role for an old toxicant?. Proc Natl Acad Sci U S A 2006, 103(43):15725-15726.
4. Benzo[a]pyrene. IARC Monographs on the evaluation of carcinogenic risks on humans. Volume 100F; 2012. Available at. http://monographs.iarc.fr/ENG/Monographs/vol100F/.
5. Brahmi D., Ayed Y., Bouaziz C., Zourgui L., Hassen W., Bacha H. Hepatoprotective effect of cactus extract against carcinogenicity of benzo[a]pyrene on liver of Balb/C mice. J Med Plants Res 2011, 5(28):4627-4639.
6. Jiang S.X., Sato Y., Kuwao S., Kamey S., Kameya T. Expression of Bcl-2 oncogene protein is prevalent in small cell lung carcinomas. J Pathol 1995, 177:135-138.
7. Sugata M., Sudeshna M., Anup R., Sukta D., Chinmay P. Tea polyphenols can restrict benzo[a]pyrene-induced lung carcinogenesis by altered expression of p53-associated in ventricular myocytes. J Biol Chem 2002, 277:38676-38682.
8. Shishodia S., et al. Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis 2003, 24(7):1269-1279.
9. Pei X.H., Nakanishi Y. Benzo[a]pyrene activates the human p53 gene through induction of nuclear factor kB activity. J Biol Chem 1999, 274(49):35240-35246.
10. Chang W.S., Lin C.C., Chung S.C., Chiang H.C. Superoxide anion scavenging effect of coumarins. Am J Chin Med 1996, 24:11-17.
11. Yue J.M., Xu J., Zhao Y., Sun H.D., Lin Z.W. Chemical components from ceratostigma willimottianum. J Nat Prod 1997, 60:1031-1033.
12. Paya M., Halliwell B., Hoult J.R.S. Interactions of a series of coumarins with reactive oxygen species: scavenging of superoxide, hypochlorous acid and hydroxyl radicals. Biochem Pharmacol 1992, 44:205-214.
13. Lin W.L., Wang C.J., Tsai Y.Y., Liu C.L., Hwang J.M., Tseng T.H. Inhibitory effect of esculetin on oxidative damage induced by t-butyl hydroperoxide in rat liver. Arch Toxicol 2000, 74:467-472.
14. Kok S.H., et al. Esculetin enhances TRAIL-induced apoptosis through DR5 upregulation in human oral cancer SAS cells. Oral Oncol 2009, 45(12):1067-1072.
15. Wang C.J., Hsieh Y.J., Chu C.Y., Lin Y.L., Tseng T.H. Inhibition of cell cycle progression in human leukemia HL-60 cells by esculetin. Cancer Lett 2002, 183(2):163-168.
16. Kuo H.C., Lee H.J., Hu C.C., Shun H.I., Tseng T.H. Enhancement of esculetin on taxol-induced apoptosis in human hepatoma HepG2cells. Toxicol Appl Pharmcol 2006, 210(1-2):55-62.
17. Earashi M., Noguchi M., Kinoshita K., Tanaka M. Effects of eicosanoid synthesis inhibitors on the in vitro growth and prostaglandin E and leukotriene B secretion of a human breast cancer cell line. Oncology 1995, 52:156-158.
18. Jia S.H., Ji Y.B. Study of esculetin-induced apoptosis in human gastric carcinoma SGC-7901 cells. Adv Mater Res 2011, 183-185:2336-2339.
19. Kaneko T., Tahara S., Takabayashi F. Inhibitory effect of natural coumarin compounds, esculetin and esculin, on oxidative DNA damage and formation of aberrant crypt foci and tumors induced by 1,2-dimethylhydrazine in rat colons. Biol Pharm Bull 2007, 30(11):2052-2057.
20. Matsunaga K., et al. Inhibitory effects of nabumetone, a cyclooxygenase-2 inhibitor, and esculetin, a lipoxygenase inhibitor, on N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats. Jpn J Cancer Res 1998, 89(5):496-501.
21. Hecht S.S., Kenney P.M., Wang M., Trushin N., Agrawal S., Rao A.V., et al. Evaluation of butylated hydroxyanisole, myo-inositol, curcumin, esculetin, resveratrol and lycopene as inhibitors of benzo[a]pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. Cancer Lett 1999, 137(2):123-130.
22. Keith R.L. Chemoprevention of lung cancer. Proc Am Thorac Soc 2009, 6(2):187-193.
23. Chu C.Y., et al. Induction of apoptosis by esculetin in human leukemia cells. Eur J Pharmacol 2001, 416(1-2):25-32.
24. Yang J.Y., Della-Fera M.A., Baile C.A. Esculetin induces mitochondria-mediated apoptosis in 3T3-L1 adipocytes. Apoptosis 2006, 8(11):1371-1378.
25. Wattenberg L.W., et al. Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice. Cancer Res 1997, 57(24):5489-5492.
26. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95(2):351-358.
27. Moron M.S., Depierre J.W., Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-tranferase activities in rat lung and liver. Biochem Biophys Acta 1979, 582(1):67-78.
28. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193(1):265-275.
29. Ren W., Qiao Z., Wang H., Zhu L., Zhang L. Flavonoids promising anticancer agents. Med Res Rev 2003, 23:519-534.
30. Panandiker A., Maru G.B., Rao K.V.K. Dose response effects of malachite green on free radical formation, lipid peroxidation and DNA damage in hamster embryo cells and their modulation by antioxidants. Carcinogenesis 1994, 15:2445-2448.
31. Sikkim H., Mulee B. Lipid peroxidation and antioxidant enzymes in the blood of rats treated with benzo[a]pyrene. Chem Biol Interact 2000, 127:139-150.
32. Mikhail F., Denissenko K., Annie P., Moon-shong T., Gerd P.P. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science 1996, 274:430-432.
33. Kim H.S., Kwack S.J., Lee B.M. Lipid peroxidation, antioxidant enzymes, and benzo[a]pyrene-quinones in the blood of rats treated with benzo[a]pyrene. Chem Biol Interact 2000, 127:139-150.
34. Emre M.H., Aktay G., Polat A., Vardt N. Effects of benzo[a]pyrene and ethanol on oxidative stress of brain, lung tissues and lung morphology in rats. Chin J Physiol 2007, 50:143-148.
35. Kim K.B., Lee B.M. Oxidative stress to DNA, protein, and antioxidant enzymes (superoxide dismutase and GSH) in rats treated with benzo[a]pyrene. Cancer Lett 1997, 113:205-212.
36. DeLeeve L.D., Wang X., Kuhlenkamp F., Kaplowitz N. Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease. Hepatology 1996, 23:589-599.
37. Franklin W.A. Diagnosis of lung cancer - pathology of invasive and preinvasive neoplasia. Chest 2000, 117:80S-89S.
38. Miranda D.G.N., Jamnik S., Santoro I.L., Uehara C. Assessment of induced sputum in the diagnostic of broncogenic carcinoma. Rev Bras Cancerol 2003, 49(2):91-98.
39. Regula K.M., Ens K., Kirshenbaum L.A. IKKβ is required for Bcl-2-mediated NF-n B activation in ventricular myocytes. J Biol Chem 2002, 277:38676-38682.
40. Mortenson M.M., Galante J.G., Gilad O., et al. BCL-2 functions as an activator of the AKT signaling pathway in pancreatic cancer. J Cell Biochem 2007, 102:1171-1179.
41. Crawford M.J., et al. Bcl-2 over-expression protects photooxidative stress-induced apoptosis of photoreceptor cells via NF-kappaB preservation. Biochem Biophys Res Commun 2001, 281(5):1304-1312.
42. de Moissac D., et al. Bcl-2 activates the transcription factor NF-kappaB through the degradation of the cytoplasmic inhibitor IkappaBalpha. J Biol Chem 1998, 273(37):23946-23951.
43. de Moissac D., Zheng H., Kirshenbaum L.A. Linkage of the BH4 domain of Bcl-2 and the nuclear factor kappaB signaling pathway for suppression of apoptosis. J Biol Chem 1999, 274(41):29505-29509.
44. Ricca A., et al. Bcl-2 over-expression enhances NF-kappaB activity and induces mmp-9 transcription in human MCF7(ADR) breast-cancer cells. Int J Cancer 2000, 86(2):188-196.
45. Wu M., et al. Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells. EMBO J 1996, 15(17):4682-4690.
46. Wang C.Y., Mayo M.W., Baldwin A.S.J. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 1996, 274(5288):784-787.
47. Van Antwer D.J., Martin S.J., Kafri T., Green D.R., Verma I.M. Suppression of tnf-α-induced apoptosis by NF-κB. Science 1996, 274:787-789.
48. Feng Z., Porter A.G. NF-kappaB/Rel proteins are required for neuronal differentiation of SH-SY5Y neuroblastoma cells. J Biol Chem 1999, 274(43):30341-30344.
49. Lee H.H., Dadgostar H., Chen Q., Shu J., Cheng G. NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc Natl Acad Sci U S A 1999, 96:9136-9141.
50. Tamatani M., et al. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J Biol Chem 1999, 274(13):8531-8538.
51. Feuillard J., et al. Inducible loss of NF-kappaB activity is associated with apoptosis and Bcl-2 down-regulation in Epstein-Barr virus-transformed B lymphocytes. Blood 2000, 95(6):2068-2075.
52. Heckman C.A., Mehew J.W., Boxer L.M. NF-κB activates Bcl-2 expression in t(14;18) lymphoma cells. Oncogene 2002, 21:3898-3908.